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Magnetic Resonance Relaxation Time and Tumor Volume 
at Multiple Time Points after Contrast Administration: 
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Objective: The purpose of this study was to investigate the time-dependent effects of contrast medium on multi-dynamic, 
multi-echo (MDME) sequence in patients with brain metastases.
Materials and Methods: This study included 7 patients with 15 brain metastases who underwent magnetic resonance (MR) 
examination which included MDME sequences at 1 minute, 10 minutes and 20 minutes after contrast injection. Two volumes 
of interests, covering an entire tumor (whole tumor) and the enhancing portion of the tumor, were derived from post-
contrast synthetic T1-weighted images. Statistical comparisons were performed for three different time delays for histogram 
parameters of the longitudinal relaxation rate (R1) and the transverse relaxation rate (R2), and lesion volumes.
Results: The mean and the median of R1 and the mean of R2 in both the whole tumor and the inner enhancing portion were 
larger on the 10 minutes delayed images than on the 1 minute or 20 minutes delayed images (mean of R1 in the whole tumor on 
the 1 minute, 10 minutes, and 20 minutes delayed images: 1.26 ms, 1.39 ms, and 1.37 ms; mean of R1 in the inner enhancing 
portion: 1.43 ms, 1.53 ms and 1.44 ms; all p < 0.017). The volumes of the whole tumor and the inner enhancing portion were 
significantly larger in the 10 minutes and 20 minutes delayed images than on the 1 minute delayed images (all p < 0.017).
Conclusion: Magnetic resonance relaxation times and the volumes of the whole tumor and the inner enhancing portion were 
measured larger on the 10 minutes or 20 minutes delayed images than on the 1 minute delayed images. The MDME sequence 
immediately after contrast injection cannot fully reflect the effects of gadolinium-based contrast agent leakage in the tissue.
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INTRODUCTION
The novel magnetic resonance imaging (MRI) quantitative 
sequence, the two-dimensional (2D) fast spin echo (FSE) 
multi-dynamic, multi-echo (MDME) sequence, enabled the 
rapid and the simultaneous sampling of physical properties 
which constitute an magnetic resonance (MR) image (1, 
2). The Synthetic MRI from the sequence enables the 
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production of images with variable contrast-weighting 
after quantifying the longitudinal relaxation rate (R1), the 
transverse relaxation rate (R2), and the proton density (3, 
4). The quantitative values can be directly measured at the 
same times on the synthetic images with good accuracy 
and reproducibility (5, 6). Several prior studies using 
the MDME sequence have investigated the image quality 
and diagnostic ability of the synthetic MRI (7-11). The 
applications of MDME sequence in neuroimaging will be 
further utilized. 
The administration of gadolinium-based contrast agent 
(GBCA) is an important part of MRI in patients with 
central nervous system (CNS) disease for the diagnosis 
and monitoring of disease progression. If the integrity of 
the blood brain barrier (BBB) is changed by a variety of 
circumstances that increase its permeability, GBCA leaks 
into the brain tissue (12). GBCA changes the absolute 
magnetic properties of tissue water, strongly increasing R1, 
slightly increases the R2 and results in hyperintensity on the 
T1-weighted image (T1WI). This effect may vary with the 
imaging time after contrast administration. In daily clinical 
practice, conventional contrast-enhanced MRI is used as a 
qualitative method that is detected as visible differences 
based on the signal intensity. Several previous studies 
investigated post-contrast time-dependent change based 
on signal intensity on T1WI (13-16). However, absolute 
signal intensity cannot provide any direct meaning and it 
should be compared to adjacent normal tissue. On the other 
hand, tissue relaxometry is a representative quantitative MR 
technique that can reflect tissue characteristics and reduce 
the subjectivity of the conventional clinical MRI. Therefore, 
it has been reported to provide objective measures of 
tissue properties in variable CNS diseases (17-23). However, 
because of the prolonged scan time, there has been a 
limitation in investigating the R1 and R2 change, resulting 
from MR contrast agent. 
Development of the new pulse sequence, MDME can 
provide diverse synthetic images and simultaneous 
quantification of R1, R2, and proton density maps in a scan 
time of approximately 6 minutes and post-processing time 
less than 1 minute (6). As the MDME sequence is promising 
method for the CNS disease, a post-contrast scan has been 
also applied to patients with multiple sclerosis or brain 
metastasis (11, 24). However, we could not find a study 
which applied MDME sequence with different times of image 
acquisition after contrast injection or evaluated the effects 
of GBCA on the physical properties of R1 and R2 using the 
MDME sequence. As brain metastasis is the most common 
intracranial tumor in adults, it is effective to investigate 
the post-contrast R1 and R2 changes in brain metastasis, as 
a representative CNS pathology that disrupts the BBB. 
Therefore, the purpose of this study was to apply the 
MDME sequence for the direct measurement of MR relaxation 
times and tumor volumes in brain metastases on synthetic 
images at different time points after contrast administration 
and to provide a reference for appropriate imaging time for 
post-contrast a MDME sequence. 
MATERIALS AND METHODS
Study Population
Our Institutional Review Board approved this study 
protocol, and informed consent was waived. Eight patients 
with intracerebral metastases, confirmed by imaging 
follow-up, underwent brain MRI with MDME sequences in 
June 2014 (15). One patient was excluded due to motion 
artifacts. Finally, seven patients (four men and three 
women; mean age, 58 years; age range, 38−66 years) with 
15 brain metastases were enrolled in this study. Metastatic 
brain tumors, which included lung adenocarcinoma (n = 11), 
renal cell carcinoma (n = 3), and rectal adenocarcinoma (n 
= 1) were investigated. Mean size of the metastases was 1.85 
± 11.17 cm (range, 0.65−4.72 cm).
MR Examination
All examinations were done using a 3T clinical scanner 
(Discovery MR750w 3.0T; GE Medical Systems, Milwaukee, 
WI, USA) with a 32-channel head coil. Quantitative 
MRI sequences were taken before and after intravenous 
administration of gadobutrol (Gadovist; Bayer Healthcare, 
Berlin, Germany) at a dose of 0.1 mmol per kilogram of 
body weight. The 2D FSE MDME sequence was performed 
utilizing 4 automatically calculated saturation delays, 2 
echo time (TE) of 21.4/85.4 ms and a repetition time (TR) 
of 4000 ms. All subjects were scanned at the following 
three different delay time points, after the administration 
of contrast agent: 1 minute, 10 minutes, and 20 minutes 
delayed imaging (Fig. 1). 
A least square fit was performed on the signal intensity 
S of each pixel of images per section to calculate the T1, 
according to the following equation (2): 
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where A is the overall intensity scaling factor considering 
the coil sensitivity, the radiofrequency chain amplification 
and the voxel volume, and the applied excitation flip angle 
S = A x PD x exp (-TE / T2) x 
1 - (1 - cos [B1θ]) x exp (-TI/T1) - cos (B1θ) x exp (-TR/T1)
1 - cos (B1α) x cos (B1θ) x exp (-TR/T1)
α and saturation pulse angle θ were 90 degrees and 120 
degrees, respectively. The B1 field was included in the 
fitting algorithm to account for B1 inhomogeneity. Details 
of the sequence and the post-processing were described by 
Warntjes et al. (2). 
Synthetic T1WI and T2-weighted image (T2WI) were 
created by the MDME sequence using a vendor-provided 
Fig. 1. Representative pre- and post-contrast synthetic T1WI and quantitative R1 and R2 maps with different delay times in 
63-year-old male patient with brain metastasis. R1 = longitudinal relaxation rate, R2 = transverse relaxation rate, T1WI = T1-weighted 
image, T2WI = T2-weighted image
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program (SyMRI7.2; Synthetic MR, Linköping, Sweden). 
Detailed parameters for the MR sequences are shown in 
Table 1.
Image Analysis 
Quantitative analysis was performed by a radiologist 
with 8 years of experience in neuroradiology. A lesion was 
defined as a mass with an abnormal focal parenchymal 
enhancement with a signal intensity higher than normal 
brain parenchyma that does not appear as a thin blood 
vessel on T1WI. R1 and R2 values and the volume (mL) of a 
lesion were measured in a volume of interest (VOI) utilizing 
a semiautomatic segmentation method in pixel analysis 
software (Nordic ICE; NordicNeuroLab, Bergen, Norway). 
Synthetic T1WI of 1 minute, 10 minutes, and 20 minutes 
delayed imaging were used as structural images for each 
VOI. A major region of interest (ROI), involving the entire 
cross-section of a metastasis at its maximum diameter 
(whole tumor including both the enhancing portion and 
the nonenhancing necrotic core) was drawn in each section 
of the three post-contrast synthetic T1WI to derive a VOI. 
Next, a selective ROI limited to the enhancing portion of 
the tumor was drawn on each section of the post-contrast 
synthetic T1WI to derive a VOI representing the enhancing 
portion of the lesion (Fig. 2). These processes were 
repeated for different time points and six VOIs were created 
for each of the lesions. For R1 and R2 values of pre-contrast 
images, synthetic T1WIs of 20 minutes delayed imaging 
were used as structural reference to define a lesion. Then, 
a histogram analysis was performed to derive the mean, 
median, skewness, and kurtosis calculated from the pixel 
values of a VOI. 
Table 1. MDME Sequence Parameters
Acquisition Parameters Quantitative Sequence (MDME)
TR (ms) 4000
TE (ms) 21.4/85.4
TI (ms)
Automatically calculated 4 
different TI
Field of view (cm) 24 x 24
Matrix 320 x 256
Section thickness (mm)   4
Section spacing (mm)   1
Number of sections 20
Flip angle 90
Echo-train length 12
Scan time (min) 5 min, 4 sec
MDME = multi-dynamic, multi-echo, TE = echo time, TI = inversion 
time, TR = repetition time
Fig. 2. Post-contrast synthetic T1WI 20 minutes after contrast administration. Regions of interest for entire tumor (second row) and 
enhancing portion of tumor (third row) to derive volumes of interest.
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Statistical Analysis
The results were reported as median values with the 
ranges in parentheses. The Friedman test was utilized 
to evaluate the differences in mean, median, skewness, 
kurtosis and the lesion volume among the three different 
time delays (14, 15). Differences were considered significant 
at p < 0.05. For post hoc pairwise multiple comparison, 
the Wilcoxon signed-rank test was used (1 minute versus 
10 minutes delayed images, 1 minute versus 20 minutes 
delayed images, and 10 minutes versus 20 minutes delayed 
images). In this case, the Bonferroni-corrected significance 
level of p < 0.017 was used. Statistical analyses were 
performed using commercially available software (PASW 
Statistics version 24.0; IBM Corp., Armonk, NY, USA, and 
MedCalc version 11.1.1.0; MedCalc software, Mariakerke, 
Belgium).
RESULTS
Both R1 and R2 values in the tumor, on the 1 minute 
delayed images, were significantly elevated compared to 
the pre-contrast images (p < 0.001 for the mean, p < 0.001 
for the median, skewness and kurtosis).
Longitudinal Relaxation Rate
The Friedman test showed significant differences in R1 
histogram parameters of the whole tumor depending on the 
three different imaging times (all p < 0.05) (Table 2). The 
post-hoc analyses for whole tumor displayed the mean and 
median of R1 were significantly increased on the 10 minutes 
delayed images compared to the 1 minute delayed images (p 
= 0.005 and p = 0.002, respectively) (Fig. 3). 
For the enhancing portion of the tumor, significant 
differences were calculated for the mean of R1 according to 
the imaging times (Friedman test, p = 0.038). In the post-
hoc analyses for the enhancing portion of the tumor, the 
mean and median R1 values were significantly larger on the 
10 minutes delayed images than on the 20 minutes delayed 
images (p = 0.01 and p = 0.012, respectively). 
The post-hoc analyses of the skewness and kurtosis 
of T1 did not show significant difference between the 
three different imaging times in both whole tumor and 
enhancing portion of the tumor (p > 0.017). The results are 
summarized in Table 2. 
Table 2. Effects of Time Delay after Contrast Injection on Histogram Parameters of Longitudinal Relaxation Rate Values in Brain 
Metastasis
Parameter Precontrast
1 Min Delayed 
Imaging
10 Min Delayed 
Imaging
20 Min Delayed 
Imaging
P for 
Friedman 
Test†
P for Post-Hoc 
Analysis‡
1 Min vs. 
10 Min
1 Min vs. 
20 Min
10 Min vs. 
20 Min
Whole tumor
Mean (ms)
0.61 
(0.56, 0.69)
1.26 
(1.12, 1.56)
 1.39 
(1.27, 1.69)
1.37 
(1.24, 1.55)
0.047* 0.005* 0.280 0.201
Median (ms)
0.59 
(0.55, 0.69)
1.22 
(1.09, 1.53)
 1.37 
(1.27, 1.73)
1.38 
(1.30, 1.64)
0.024* 0.002* 0.132 0.629
Skewness
0.71 
(0.27, 1.05)
0.37 
 (-0.07, 0.97)
 0.16 
 (-0.23, 0.72)
 0.23 
 (-0.52, 0.57)
0.022* 0.233 0.088 0.118
Kurtosis 
0.29 
 (-0.09, 6.15)
0.30 
 (-0.38, 1.99)
0  
 (-0.52, 0.48)
 0.06 
 (-0.47, 0.55)
0.038* 0.173 0.173 1.000
Enhancing portion of tumor
Mean (ms)
1.43 
(1.30, 1.60)
 1.53 
(1.45, 1.72)
 1.44 
(1.32, 1.56)
0.038* 0.053 0.711 0.010*
Median (ms)
1.36 
(1.28, 1.56)
 1.54 
(1.39, 1.73)
 1.44 
(1.32, 1.55)
0.057 0.017 0.887 0.012*
Skewness
0.72 
(0.08, 1.14)
 0.34 
(0, 0.70)
 0.40 
(0.06, 0.63)
0.420 0.156 0.191 0.570
Kurtosis 
1.21 
 (-0.31, 2.31)
-0.06 
 (-0.41, 0.68)
-0.30 
 (-0.57, 0.20)
0.085 0.031 0.088 0.532
Data are median values with IQRs in parentheses. *Significant p value for each test, †For Friedman tests, p < 0.05 was considered 
significant difference, ‡In post-hoc analyses, Bonferroni-corrected significance level of p < 0.017 was used. IQRs = interquartile ranges
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Transverse Relaxation Rate
In the whole tumor, the mean R2 was significantly different 
according to the three different imaging delay times (Friedman 
test, p = 0.038). The other parameters were not significantly 
altered depending on the imaging times (Friedman test, all 
p > 0.05) (Table 3). In the post-hoc analyses for the whole 
tumor, the mean of R2 showed a significant decrease on the 
20 minutes delayed images as compared to the 10 minutes 
delayed images (p = 0.011) (Fig. 3). 
For the enhancing portion of the tumor, the mean and 
median of the pixel values were significantly different in R2 
for the three time delays (Friedman test, p = 0.007 for both 
the mean and median). In the post-hoc analyses for the 
enhancing portion of the tumor, the mean and the median 
of R2 were much larger on the 10 minutes delayed images 
as compared to the 20 minutes delayed images (p = 0.006 
for the mean and p = 0.002 for the median). The results are 
summarized in Table 3. 
Volume
There was a significant difference in the volume of whole 
tumor for the three different imaging times (p = 0.022). 
The median values of the volume of whole tumor, according 
to the imaging time, were 0.43 mL (interquartile range [IQR], 
0.18−2.67 mL) on the 1 minute delayed images, 0.59 mL 
(IQR, 0.21−3.09 mL) on the 10 minutes delayed images and 
0.71 mL (IQR, 0.26−3.50 mL) on the 20 minutes delayed 
images. In the post hoc analysis with Wilcoxon signed-rank 
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Fig. 3. Box and whisker plots display distribution of mean R1 and R2 in whole tumor and enhancing portion of tumor, respectively. 
Central box represents values from lower to upper quartile (25–75 percentile). Middle line represents median. Horizontal line extends from 
minimum to maximum value, excluding outside and far out values that are displayed as separate points. 
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tests conducted with a Bonferroni correction, there were 
significant increases in the volume of whole tumor on the 
10 minutes and 20 minutes delayed images as compared 
to the 1 minute delayed images (p = 0.001 and p = 0.002, 
respectively). There was no significant difference between 
the 10 minutes and 20 minutes delayed images (p = 0.028).
The volume of the enhancing portion of tumor also 
showed a statistically significant difference for the three 
different imaging times (p < 0.001). The median values 
for the volume of the enhancing portion of the tumor, 
according to the imaging time were 0.29 mL (IQR, 0.12−1.73 
mL) on the 1 minute delayed images, 0.54 mL (IQR, 
0.13−2.61 mL) on the 10 minutes delayed images and 0.69 
mL (IQR, 0.21−3.37 mL) on the 20 minutes delayed images. 
In the post hoc analysis, the volume of the enhancing 
portion of the tumor revealed a significant increase with 
the delayed imaging time (both p = 0.001 between the 1 
minute and 10 minutes delayed images and between the 
1 minute and 20 minutes delayed images and p = 0.01 
between the 10 minutes and 20 minutes delayed images).
DISCUSSION
Quantitative relaxometry can be utilized to obtain 
fundamental and absolute information on tissue properties 
(22). As recently introduced synthetic MRI enabled direct 
measurement of R1 and R2 values within a reasonable 
time, we applied the sequences to investigate the time-
dependent changes of R1 and R2 on the post-contrast MRI 
and measured them in brain metastases at three delay time 
points. We observed the mean of R1 and R2 in the whole 
tumor were higher on the 10 minutes delayed images than 
on the 1 minute delayed images. For the enhancing portion 
of the tumor, the mean and the median of R1 and the mean 
of R2 were higher on the 10 minutes delayed images than 
on the 20 minutes delayed images. Therefore, R1 and R2 
values measured on the synthetic MRI were significantly 
changed at 10 minutes after contrast injection. In addition, 
we observed that volumes of the whole tumor and the 
inner enhancing portion were significantly larger at the 
10 minutes delayed images as compared to the 1 minute 
delayed images. 
There have been a few studies that reported the time 
Table 3. Effects of Time Delay after Contrast Injection on Histogram Parameters of Transverse Relaxation Rate Values in Brain 
Metastasis
Parameter Precontrast
1 Min Delayed 
Imaging
10 Min Delayed 
Imaging
20 Min Delayed 
Imaging
P for 
Friedman 
Test†
P for Post Hoc 
Analysis‡
1 Min vs. 
10 Min 
1 Min vs. 
20 Min
10 Min vs. 
20 Min
Whole tumor
Mean (ms)
9.88 
  (7.52, 11.78)
10.26 
(8.74, 12.75)
10.72 
(8.64, 13.61)
10.28 
(8.46, 11.89)
0.038* 0.820 0.088 0.011*
Median (ms)
9.92 
  (7.46, 11.06)
  9.88 
(8.87, 13.37)
    10.00
(8.87, 13.89)
11.01 
(8.74, 12.08)
0.337 0.826 0.320 0.048
Skewness
0.73 
(0.08, 1.06)
  0.14 
(-0.66, 0.59)
  0.13 
(-0.32, 0.87)
  0.29 
(-0.24, 0.77)
0.627 0.570 0.820 0.589
Kurtosis 
0.18 
 (-0.38, 2.29)
 -0.24 
(-0.55, 0.46)
  0.10 
(-0.39, 0.61)
-0.15 
(-0.37, 2.19)
0.549 0.233 0.334 0.349
Enhancing portion of tumor
Mean (ms)
10.40 
(9.71, 12.69)
10.72 
(9.41, 14.11)
10.22 
(8.79, 11.92)
0.007* 0.865 0.031 0.006*
Median (ms)
10.37 
(9.51, 13.30)
10.20 
(9.40, 14.04)
 9.84 
(8.74, 12.08)
0.007* 0.887 0.020 0.002*
Skewness
  0.16 
(-0.37, 0.48)
  0.21 
(-0.23, 0.57)
 0.29 
(-0.18, 0.68)
0.591 0.594 0.733 0.910
Kurtosis 
  0.04 
(-0.51, 0.64)
  0.38 
(-0.27, 0.84)
0 
(-0.51, 0.82)
0.420 0.609 0.609 0.570
Data are median values with IQRs in parentheses. *Significant p value for each test, †For Friedman tests, p < 0.05 was considered 
significant difference, ‡In post-hoc analyses, Bonferroni-corrected significance level of p < 0.017 was used. 
790
Kang et al.
Korean J Radiol 19(4), Jul/Aug 2018 kjronline.org
dependent changes of MR relaxation times. We found a 
previous study which investigated time-dependent changes 
in the local T1 relaxation time (T1) in variable brain tumors 
after the intravenous injection of GBCA, using a magnetic 
focusing technique (25). T1 values of the tumors were 
measured serially for 60 minutes, and most values of T1 
reached the minimal values at 5 minutes or, at latest, 10 
minutes after the injection of GBCA (25). Similar to these 
results, our study the using synthetic MRI also revealed 
that measured MR relaxation times on the delayed scan 
were significantly different from those on the immediate 
post-contrast scan. In addition, we included the skewness 
and kurtosis in the analyses because they are biomarkers 
for tumor heterogeneity (26-29). Although Friedman test 
revealed that the skewness and kurtosis of R1 for the whole 
tumor were significantly different according to the different 
imaging delay times, their differences were attenuated in 
the post-hoc analyses. Based on our findings and previous 
knowledge, post-contrast quantitative MRI needs to be 
acquired at least 5 minutes after contrast injection to 
reflect enough changes in MR relaxation times. 
The measurability of a disease is important for the 
assessment of response in patients with malignant tumors 
who are given anticancer treatments. In our study, two 
kinds of volumes for the whole tumor (including enhancing 
portion and nonenhancing necrotic core) and the inner 
enhancing portion were significantly larger on the 10 
minutes and 20 minutes delayed images as compared 
to the 1 minute delayed images. Whereas no significant 
difference was observed between the 10 minutes and 20 
minutes delayed images in the whole tumor, the volume 
of the enhancing portion of the tumor was larger on the 
20 minutes delayed images than the 10 minutes delayed 
images. Our results are similar to a few previous reports, 
which showed the lesion contrast from signal intensities 
improved with delayed imaging time (13, 14). As the post-
contrast synthetic T1WIs were used as structural images for 
each VOI, we could indirectly validate the time-dependent 
changes in tumor volume measured by the MDME sequence 
as compared to the conventional MR imaging. 
Post-contrast synthetic MRI could demonstrate the 
R1 and the R2 changes caused by GBCA leakage in the 
brain metastasis. By using synthetic MRI, the changed 
MR relaxation times were easily and directly measured 
and compared between pre- and post-contrast scans. In 
addition, the changes were much larger on the delayed 
scan rather than 1 minute delayed scan. Even though 
these results are predictable, there has been no prior study, 
which put a theory on the synthetic MRI. Therefore, this 
preliminary study is meaningful as a reference for future 
studies using post-contrast synthetic MRI.
The current study has several limitations. First, the 
number of patients was small. Because of the limitation 
of the acquisition time, it was difficult to obtain MDME 
sequences four times in many of these patients. Second, 
in the case of multiple lesions in the same patient, 
each lesion was regarded as an independent lesion. In 
addition, the constitution of sample was heterogeneous, 
and the pathology of metastases might have affected the 
time-dependent changes in tissue relaxation. However, 
our purpose was not to differentiate the pathology of 
metastases, but to analyze the time-dependent effects of 
the contrast medium on MDME sequence in an enhancing 
mass. We could obtain reliable results by studying various 
histogram parameters and statistical verification. Third, 
our study did not investigate time-dependent changes of 
R1 and R2 with a shorter interval of imaging time delays. 
This was also caused by the limitation of acquisition time. 
In addition, it took 5 minutes and 4 seconds to acquire a 
MDME sequence, the time interval used in our study seems 
to be applicable for investigating the time-dependent 
changes of tissue relaxation times in brain metastasis. 
In conclusion, the MDME sequence immediately after 
contrast injection cannot fully reflect the effects of GBCA 
leakage in a tissue. Both the changes in the MR relaxation 
times and the volume of a tumor were larger on the 10 
minutes or 20 minutes delayed images rather than on the 1 
minute delayed images. As the post-contrast synthetic MRI 
can provide objective change of tissue properties related 
to contrast leakage in various CNS diseases, its application 
in neuroimaging will be further expanded. Our results may 
provide a reference for appropriate imaging time for post-
contrast MDME sequence.  
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